Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Indian J Physiol Pharmacol ; 2008 Jul-Sept; 52(3): 249-254
Artigo em Inglês | IMSEAR | ID: sea-145874

RESUMO

In the present study, effects of intracerebroventricular (icv) administration of histamine, mepyramine (H1-receptor antagonist) and famotidine (H2-receptor antagonist) have been investigated on the formalin test in rats. Subcutaneous injection of formalin (50 μl, 1%) into the ventral surface of the left hind paw produced a marked biphasic pain response (first phase: 0–5 min and second phase: 15–45 min). All the performed treatments did not significantly influence the first phase of pain. Histamine at the doses of 10 and 40 μg and mepyramine and famotidine at the same doses of 20 and 80 μg, significantly (P<0.05) decreased the late phase of formalin-induced pain. Pretreatments with mepyramine and famotidine at the same dose of 80 μg, significantly (P<0.05) prevented the histamine (40 μg)-induced antinociception. These results indicate that brain histamine produces antinociception, and both central H1 and H2 receptors may involve in the histamine-induced antinociception in the formalin test in rats.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA